We encourage you to secure your participation at this landmark event and become an integral part of shaping the future of sports medicine.
We look forward to welcoming you to Qatar.
Secure your spot now and be part of shaping the future of sports medicine!
Event: | Aspetar World Conference 2025 |
Activity Code: | HGI-03-P164 |
Dates: | - Thursday 9 October 2025 – 8:30-18:00
- Friday 10 October 2025 – 9:00-18:00
- Saturday 11 October 2025 – 9:00-17:00
|
Venue: | |
Cost: | Early Bird Registration is now open! Register by May 31, 2025 to get a special rate: - 3-Day Conference Registration: QAR 1350
- Per-day Registration: QAR 720
Registration rates after May 31, 2025: - 3-Day Conference Registration: QAR 1500
- Per-day Registration: QAR 800
|
Target Audience: | Physicians, Allied Healthcare Practitioners, Nurses, Dentists, Pharmacists, Complimentary Medicine, Others (Researchers, Scientists, Coaches, Massage Therapists |
CPD Points | Maximum of 18.0 “Category 1” credit hours |
Overall learning objectives:
On completion of this activity, participants will be able to:
- Improve athlete health and performance by applying latest diagnostic, treatment, and rehabilitation strategies for sports injuries and medical conditions in sport
- Adapt orthobiologics, regenerative medicine, and injury prevention strategies into clinical practice to optimise recovery and reduce risk of (re)injury
- Assess mental health, oral health, sleep, and recovery strategies to support athletes' overall physical and psychological health for sustained performance
- Develop teamwork across sports medicine disciplines to deliver comprehensive and personalised athlete care
- Discuss the role of wearable technology, artificial intelligence, and other data-driven solutions to monitor, enhance, and individualise athlete performance and recovery strategies
- Develop tailored health and performance approaches for specific athlete populations, including female and young athletes, and those competing in challenging environments
DHP Accreditation statement:
This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions – Accreditation Section (DHP-AS) and is approved for a maximum of 18.0 hours.
Scientific Planning Committee:
Paul Dijkstra (chairperson), Abdulaziz Jaham Al-Kuwari (Conference President and chairperson, Conference Organising Committee), Sofie Nelis, Faten Smiley, Dorothy Lechicki, Omar AlSeyrafi, Khalid Alkhelaifi, Marco Cardinale, Shaima AlKhaldi, Marcelo Bordalo, Salwa Allenjawi, Alan Getgood, Elisabet Hagert, Cristiano Eirale, Guido Pieles, Konstantinos Epameinontidis, Ibrahim Al Hussein, Mohammed Alsaey, Mokhtar Chaabane, Raouf Nader Rekik, Valter Di Salvo, Zainab Al Sarraf, Ayesha Masood.
The Scientific Planning Committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of the CPD activity and has implemented procedures to manage any potential or real conflicts of interest.
Dr. Pieter D'Hooghe
Chief Medical Officer - Orthopaedic Surgeon - Aspetar
Dr. Jamal Al Khanji
Chief Patient Experience Officer - Aspetar
Dr. Paul Dijkstra
Director of Medical Education and Consultant Sport and Exercise Medicine Physician
Dr. Stephen Seiler
Professor in Sport Science at University of Agder in Kristiansand, Norway
Dr. Enda King
Head of Elite Performance and Development - Aspetar
Prof. Christa Janse Van Rensburg
Professor of Sports and Exercise Medicine (SEM) at the University of Pretoria (UP)
Prof. Roald Bahr
Director of the Aspetar Sports Injury & Illness Prevention Programme - Aspetar
Dr. Marcelo Bordalo
Chief of Radiology - Aspetar
Dr. Khalid AlKhelaifi
Orthopaedic Surgeon - Aspetar
Dr. Elisabet Hager
Consultant Hand & Orthopaedic Surgeon - Aspetar
Dr. Abdulqadir Nashwan
Assistant Executive Director of Nursing and Midwifery for Research at Hamad Medical Corporation (HMC)
Dr. Carmen Adamuz
Consultant Cardiologist - Aspetar
Dr. Cristiano Eirale
Chief of Sports Medicine - Aspetar
Dr. Andrea Mosler
Specialist Sports and Exercise Physiotherapist and Senior Research Fellow at La Trobe University
Dr. Celeste Geertsema
Sports Medicine Physician - Aspetar
Dr. Al Getgood
Chief of Surgery - Complex Knee Surgeon - Aspetar
Dr. Eirik Halvorsen
Scientific Researcher - Aspetar Sports Injury and Illness Prevention Programme (ASPREV)
Dr. Juan Manuel Alonso
Sports Medicine Physician - Aspetar
Dr. Mohammed Alsaey
Director of Sports Dentistry, Consultant in Oral Surgery - Aspetar
Dr. Omar AlSeyrafi
Sports Medicine Physician - Aspetar
Dr. Berte Bøe
Consultant Orthopaedic Surgeon, Head of the Arthroscopy Unit at Oslo University Hospital
Prof. Marco Cardinale
Executive Director of Research and Scientific Support - Aspetar
Dr. Gazi Huri
Orthopaedic Surgeon - Aspetar
Dr. Roula Kotsifaki
Head of Assessment Lab - Aspetar
Dr. Guido Pieles
Head of Sports Cardiology and Screening
Dr. Rod Whiteley
Assistant Director incharge of Clinical Projects and Quality - Aspetar
Prof. Dave Collins
Professorial Fellow at the University of Edinburgh
Dr. Pedro Bernáldez
Director of SportMe Medical Center in Spain
Prof. Sébastien Racinais
Research engineer at the institute sports of Montpellier (France).
Dr. Sofie Nelis
General Medicine and MSK Physician - Aspetar
To download a copy of the agenda, click here.
Call for Abstracts – Aspetar World Conference 2025
It is our pleasure to share with you the Aspetar World Conference 2025 (AWC25) call for abstracts information.
Conference summary
The Aspetar World conference 2025 – Precision athlete health and performance, will be held in Doha from 9-11 October 2025 and explore the latest strategies to optimize athlete healthcare and performance. Aspetar’s multidisciplinary approach will be highlighted across the four key streams: 1. sports injuries, 2. medical conditions in sport, 3. sports science and performance and 4. sports pharmacy, nursing and dentistry.
Call for abstracts
We are inviting abstract submissions for poster and oral presentations. We welcome abstracts in which delivery and practice of medicine and science in athlete health and performance are showcased, however the Free Communications Committee will take the final decision depending on the structure of the final Scientific Programme.rgistrati
KEY DATES
Deadline for abstract submission | 1st June 2025 – 23.59 AST |
Notification of your abstract acceptance | By 1st July 2025 |
Deadline for presenter’s registration* | By 1st August 2025 |
Upload e-poster or presentation | By 1st October 2025 |
* The first named abstract author must register to the conference, in order for their poster abstract to be included within the final program
Rules of Submission
- Each person is permitted to submit and be first author on one abstract. You may co-author as many other abstracts as desired.
- The first named author must be a delegate for the conference.
- All authors must approve the abstract.
- Final abstract acceptance decision is the exclusive right of the AWC25 Free Communications Committee.
- Human studies must have gained appropriate ethical approval from an institutional review board (IRB) and data must have been collected with participant informed consent in place.
- Full disclosure of conflict of interests are required, in line with the following policy. In accordance with Qatar Department of Health Practitioners - Accreditation Section and Aspetar CME/CPD Conflict of Interest Policy, all abstract authors must disclose any commercial and/or financial interests over the past 24 months which have a direct or indirect bearing of the design, content orconclusions/recommendations from the presented abstract. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care or related goods or services consumed by, or used on, patients or athletes. Relationships withgovernmental agencies and organizations that do not fit the above definition do not have to be disclosed. Also, you must disclose relevant financial relationships your spouse or life partner has with commercial or financial interests. In accordance with requirements, failure or refusal to provide disclosure information in a timely manner will result in the disqualification of your participation in this activity. This information will only be collated if your abstract is accepted.
- The first named abstract author must pay any associated registration fee and all other costs associated with travel to the conference, in order for their abstract to be included within the final program. Accepted abstract submissions will receive a 50% discount on conference registration fees.
- If a speaker needs to apply for a visa for Qatar, they must ensure to obtain it no later than 1st of October 2025. The Free Communications Committee may require providing confirmation of obtaining the visa before including the paper to the final program.
- Submissions are only accepted electronically and must be submitted no later than 1 June 23:59 Arabia Standard Time (AST). Late submissions will not be accepted and thus will not be considered. Submissions are to be submitted electronically to this LINK.
- All submissions must adhere to the stated standardized abstract template and instructions, any submissions which do not, will not be considered.
- Accepted poster submissions will be available at the conference as e-Posters (no physical printing is necessary), and accepted abstract submitters will be expected to send and/or upload their completed poster before 23:59 (AST) 1 October 2025, in line withprovided instructions. Failure to do so will result in the poster abstract being withdrawn.
- From the submitted and accepted abstracts, 3 posters and 3 oral presentations will be chosen on merit (final decision is the exclusive right of the Free Communications Committee) during the free communications consideration process. Any prizes (which are not confirmed or guaranteed) will be announced in due course.
Submit your abstract here.
Submission guidelines
- Length: The abstract should be a maximum of 500 words (excluding tables and/or figures)
- Title: A brief title
- Authors: First and last full name of all authors, with any middle name limited to a maximum of two initials (e.g. Joe A.B. Bloggs). Academic degrees (e.g. MD, PhD, etc.) and fellowships (e.g. FACSM) are not to be included.
- Institutions: Each author is to include a maximum of three affiliations. Departments are not to be included.
- Text: The abstract must be informative adopting a structured composition, including the following mandatory headings: TITLE, INTRODUCTION, AIM, METHODS, summary of RESULTS, and CONCLUSIONS. It is unsatisfactory to state the results will be discussed. 2 figures and/or tables may be included in the abstract.
- Ethical Institutional Review Board (IRB) Approval Number: This should be included at the end of the abstract.
- Funding Source(s): This should be included at the end of the abstract.
- Abstracts of experimental, observational, and meta-analytic studies must include data to substantiate the conclusions being drawn. Systematic reviews without meta-analyses are not acceptable. It is not satisfactory to simply describe what was found(such as, “the treatment group increased their fitness more than the control group”) or to only include statistical results (such as, “associations were significant at p < .05”) – the inclusion of effect size is strongly encouraged [if adopting a magnitude based inferences (MBI) approach, such reporting must only be conducted on those comparisons that have a significant p value within the adopted statistical model] to support inferentially determined differences and/or relationships. The lack ofinclusion of experimental data may result in the abstract being rejected.
- The abstract must be written in high-quality American English and be grammatically correct. It is strongly recommended that if English is not your first language, you seek proof reading assistance from a colleague with appropriate skills. Unintelligible abstracts will not be given further consideration.
Exclusive Accommodation Packages! Coming Soon